Hong Liu

机构：Shenyang Pharmaceutical University, IE University, Nanjing University of Chinese Medicine, Xinjiang Medical University, China Pharmaceutical University, South China Normal University, Chinese Academy of Sciences, ShanghaiTech University, Chinese Academy of Engineering, North West Agriculture and Forestry University, Asian Health Coalition, Shanghai Institute of Materia Medica, Drug Discovery Laboratory (Norway), Institute for Advanced Study, Food and Drug Administration, University of Chinese Academy of Sciences · ORCID：0000-0003-3685-6268

发表论文 996 篇 · 总被引 44203 次 · h-index 73

代表论文

• The Current Toolbox for Covalent Inhibitors: From Hit Identification to Drug Discovery (2025 · JACS Au · 被引 14)
• Pretargeted Mitochondrial Delivery of Organoarsenicals for Cancer Immunotherapy (2025 · Journal of the American Chemical Society · 被引 13)
• Understanding interspecies drug response variations between human and rodent P2X7 receptors (2025 · Nature Communications · 被引 8)
• Extracellular vesicles from Akkermansia muciniphila block NACHT, LRR, and PYD domains-containing protein 3 inflammasome activation to promote cognitive recovery in aged mice under sevoflurane anesthesia (2025 · Behavioural Pharmacology · 被引 3)
• Ru(II)- and Rh(III)-Catalyzed C–H Activation/Annulation of Pyrazolidinones with CF 3 -Imidoyl Sulfoxonium Ylides (2025 · The Journal of Organic Chemistry · 被引 2)
• Regio- and Diastereoselective Construction of Multisubstituted C -Vinyl Glycosides via Nickel-Catalyzed Three-Component Reaction of Alkynes (2025 · ACS Catalysis · 被引 2)